Thursday, 27 July 2017

As drug prices drop, generics makers fight back with deals

NEW YORK (Reuters) - Generic drug makers are turning to M&A to shield themselves against a concerted effort by U.S. regulators to crack down on steep drug prices.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)